ML18011A323

GL Report from Mallinckrodt Pharmaceuticals Regarding Transfer of Tritium Exit Signs

ML18011A323
Person / Time
Issue date:	12/19/2017
From:	Eckles J Mallinckrodt Pharmaceuticals
To:	Office of Nuclear Material Safety and Safeguards
References
Download: ML18011A323 (8)